Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125243731 | 12524373 | 1 | I | 20140821 | 20140822 | 20160704 | 20160704 | EXP | PHHY2014CA107264 | NOVARTIS | 66.33 | YR | F | Y | 0.00000 | 20160704 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125243731 | 12524373 | 1 | PS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 30 MG, EVERY 4 WEEKS | 630.689026 | MG | Y | 21008 | 30 | MG | SUSPENSION | /month | |||
| 125243731 | 12524373 | 2 | SS | AFINITOR | EVEROLIMUS | 1 | Oral | 10 MG, QD | Y | 0 | 10 | MG | QD | ||||||
| 125243731 | 12524373 | 3 | SS | SUTENT | SUNITINIB MALATE | 1 | Oral | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125243731 | 12524373 | 1 | Pancreatic neuroendocrine tumour |
| 125243731 | 12524373 | 2 | Pancreatic neuroendocrine tumour |
| 125243731 | 12524373 | 3 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125243731 | 12524373 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125243731 | 12524373 | Abdominal pain upper | |
| 125243731 | 12524373 | Arthralgia | |
| 125243731 | 12524373 | Blood glucose increased | |
| 125243731 | 12524373 | Blood magnesium decreased | |
| 125243731 | 12524373 | Blood pressure systolic increased | |
| 125243731 | 12524373 | Feeding disorder | |
| 125243731 | 12524373 | Feeling abnormal | |
| 125243731 | 12524373 | Gait disturbance | |
| 125243731 | 12524373 | H1N1 influenza | |
| 125243731 | 12524373 | Headache | |
| 125243731 | 12524373 | Hepatic neoplasm | |
| 125243731 | 12524373 | Hepatic pain | |
| 125243731 | 12524373 | Injection site pain | |
| 125243731 | 12524373 | Injection site swelling | |
| 125243731 | 12524373 | Ligament sprain | |
| 125243731 | 12524373 | Malaise | |
| 125243731 | 12524373 | Musculoskeletal pain | |
| 125243731 | 12524373 | Pain | |
| 125243731 | 12524373 | Pertussis | |
| 125243731 | 12524373 | Stomatitis | |
| 125243731 | 12524373 | Tumour pain | |
| 125243731 | 12524373 | Weight decreased | |
| 125243731 | 12524373 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125243731 | 12524373 | 1 | 20140722 | 20160504 | 0 | |
| 125243731 | 12524373 | 2 | 20150305 | 2016 | 0 |